Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG. - Wikidata - wikimedia - TriplyDB

Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.

Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.

http://www.wikidata.org/entity/Q46270281

about

Brain tumors Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods 6-[18F]fluoro-L-DOPA: a well-established neurotracer with expanding application spectrum and strongly improved radiosyntheses PET probes beyond (18)F-FDG The development, past achievements, and future directions of brain PET PET/CT in paediatric malignancies - An update The comprehensive neuro-oncology data repository (CONDR): a research infrastructure to develop and validate imaging biomarkers Repeatability of 18F-FLT PET in a Multicenter Study of Patients with High-Grade Glioma.Postradiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progression?Molecular imaging: 18F-FDG PET and a whole lot more.Invited review--neuroimaging response assessment criteria for brain tumors in veterinary patients Progress on the diagnosis and evaluation of brain tumors.Advances in Magnetic Resonance and Positron Emission Tomography Imaging: Assessing Response in the Treatment of Low-Grade Glioma.Non-invasive metabolic imaging of brain tumours in the era of precision medicine.Neuroimaging of Peptide-based Vaccine Therapy in Pediatric Brain Tumors: Initial Experience.The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy.¹⁸F-FLT and ¹⁸F-FDOPA PET kinetics in recurrent brain tumors Technology Insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugs.3'-Deoxy-3'-[(18)F]fluorothymidine and O-(2-[(18)F]fluoroethyl)-L-tyrosine PET in Patients with Suspicious Recurrence of Glioma after Multimodal Treatment: Initial Results of a Retrospective Comparative Study The Feasibility of (18)F-Fluorothymidine PET for Prediction of Tumor Response after Induction Chemotherapy Followed by Chemoradiotherapy with S-1/Oxaliplatin in Patients with Resectable Esophageal Cancer.(18)F-FLT PET/CT imaging in a Wister rabbit inflammation model.Advances in MRI assessment of gliomas and response to anti-VEGF therapy.Evaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls RANO criteria into question.Dynamic small-animal PET imaging of tumor proliferation with 3'-deoxy-3'-18F-fluorothymidine in a genetically engineered mouse model of high-grade gliomas.Molecular imaging of gliomas with PET: opportunities and limitations.18F-FDG PET/CT for image-guided and intensity-modulated radiotherapy.Imaging biomarkers of brain tumour margin and tumour invasion Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PET Efficient radiosynthesis of 3'-deoxy-3'-18F-fluorothymidine using electrowetting-on-dielectric digital microfluidic chip Molecular imaging in cancer treatment.3'-Deoxy-3'-18F-fluorothymidine PET predicts response to (V600E)BRAF-targeted therapy in preclinical models of colorectal cancer.Limits of [18F]-FLT PET as a biomarker of proliferation in oncology The role of DNA synthesis imaging in cancer in the era of targeted therapeutics Imaging and cancer: a review.Imaging of treatment response to the combination of carboplatin and paclitaxel in human ovarian cancer xenograft tumors in mice using FDG and FLT PET (18)F-Fluorothymidine PET-CT for resected malignant gliomas before radiotherapy: tumor extent according to proliferative activity compared with MRI.PET-specific parameters and radiotracers in theoretical tumour modelling.

P2860

Q24605136-022932EE-2A13-4FB5-9D44-43325D27C38A Q24632791-C8C2848D-B1BC-4585-80C4-DC36D145ECCC Q26796223-83011AF8-36EE-4B5A-83FD-54A54E9349F0 Q26853308-91DD643F-6E03-4CF1-879A-5948D6839361 Q26853516-9232D3C8-FCFB-4E00-A799-6A1DA9880B20 Q26991479-53F1AA4D-3568-444A-A4C7-BB9918DC735F Q27004457-02A544F3-3534-4B25-AC84-61B61EA00C8F Q27026331-88819725-FD86-4E02-9439-3EBC47EED9C6 Q28066175-1CD9C4D6-7119-4F2E-81E9-CDDE148C16E7 Q28608269-8424C3A3-CEA4-4D87-A2C5-8E006BA35481 Q30275817-462A739C-3091-4B4F-BFEA-0C1BF8AD08D2 Q30418915-963C8664-BE15-4690-8731-C3335FFFB226 Q30482989-CA853D06-5C5C-4FD9-879F-BC11988A463B Q30692995-D6D09B39-BC24-44D2-966F-7E97FE7680F3 Q30714285-1A8C86FC-E580-4F8F-A195-3BDE296077FD Q30967370-633B4FAF-F99F-44F7-9DE0-30470FE4F8B5 Q31115540-45F3A73A-DBB1-4796-83CE-BE30B9A86190 Q31144824-4E0AF72E-BDF8-4A22-BC67-6DCAF9E09773 Q31156299-11064CF2-E940-4DD4-A999-2D50F48D62E9 Q33560943-A8480156-45EB-4C39-8F16-C4A61A72A438 Q33696408-79281C55-AE97-4E5B-8780-771489604163 Q33704202-0E820A74-805E-4D94-A3C2-61E173179EB4 Q33704276-E8164DF1-0CD1-4A86-874E-AF5959573979 Q33769525-9AC500A2-B0A3-472C-8828-9C3B5A5AD346 Q33793253-FBD37C7D-4E3A-4324-A6EA-E11E5D49EA0D Q33894461-6AC8C2AC-61AD-44EB-8E14-FAA335764CA3 Q33924541-093A852D-C858-457A-AEAD-8FD00DA0C9A4 Q33961188-4DF7699D-78F4-4B5E-B66C-1A8D98E15DDA Q33973367-CA3F7B0A-2D57-408B-820C-C5C31C1825E3 Q34203946-BDF96E59-B551-4AE7-A4FA-CF757B410A3C Q34235986-BA37A708-F1E3-4682-A4F9-01624ED8605D Q34394072-311E8537-AAED-42E5-8319-DCAEA7D26B26 Q34496670-503223B3-3B8A-435C-B2C1-FA1CC4F3CA15 Q34557875-819378DA-5C40-4338-8CB1-3CA366B2DB06 Q34648592-B03562EC-CD2B-4448-B92F-23BF32BA576F Q34907192-3BDB4C38-A399-44BF-A5A8-39159C0D838F Q34977050-E3A9012B-674E-4D4D-9601-6BB63475B041 Q35081130-F19B5692-162F-4841-86CE-FB720AE21D5E Q35148054-2F3A53FE-3FC7-4E8E-A155-15BA969622FB Q35151586-28A5B8AF-9BC7-41C7-B1C0-0045514E51D6

P2860

Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.

http://www.wikidata.org/entity/Q46270281

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.

@en

Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.

@nl

type

label

Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.

@en

Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.

@nl

prefLabel

Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.

@en

Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.

@nl

P1433

Q46270281-483875F1-7FB1-4866-A209-7732D3E9D203

P1476

Q46270281-5894764E-8FD1-4648-911D-1B1F2D588895

P2093

Q46270281-0CCA2882-7375-4158-949E-A04D2815307A

Q46270281-1ECD1989-75E5-423A-AA7A-688F88293254

Q46270281-1F766A46-4D74-4E30-A013-758DFCBB97C5

Q46270281-287F3110-F2CC-4238-86A9-A807CAAB5331

Q46270281-69CDC930-3C2F-4832-A117-7C15683D4D59

Q46270281-6D48419C-969D-4637-9AE9-EFF4DD913534

Q46270281-76D69EEB-E235-4299-B929-0AECB070AA14

Q46270281-8927E40E-89E4-4E8D-B332-B6FD22392E0F

Q46270281-D33459A1-A6EF-42CF-9FC6-49D0CECAB0B5

Q46270281-ED4F7896-C487-4157-8740-3DE26D2B236E

P304

Q46270281-B51FB8DE-9FEC-440F-8068-CDA5766F1BA5

P31

Q46270281-F72F1499-B45C-426F-BFFB-CBA0048A49D0

P407

Q46270281-987E331E-5E41-493C-9CD1-3184EE4FF525

P433

Q46270281-1A777C88-64EA-4684-AD13-B93CF5A02711

P478

Q46270281-31F5D9DF-E222-45AA-BEA3-B4E55A3675A6

P577

Q46270281-F0D01084-AB66-4865-BCCC-9B54D2F17A40

P698

Q46270281-CC1A8B08-DA09-4211-A60D-048A0F5D4CB4

P1433

The Journal of Nuclear Medicine

P1476

Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG

@en

P2093

Daniel H S Silverman

http://www.w3.org/2001/XMLSchema#string

Johannes Czernin

http://www.w3.org/2001/XMLSchema#string

Linda Liau

http://www.w3.org/2001/XMLSchema#string

Marvin Bergsneider

http://www.w3.org/2001/XMLSchema#string

Michael E Phelps

http://www.w3.org/2001/XMLSchema#string

Nagichettiar Satyamurthy

http://www.w3.org/2001/XMLSchema#string

Nirav Kamdar

http://www.w3.org/2001/XMLSchema#string

Paul Mischel

http://www.w3.org/2001/XMLSchema#string

Timothy Cloughesy

http://www.w3.org/2001/XMLSchema#string

Wei Chen

http://www.w3.org/2001/XMLSchema#string

P304

945-952

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15937304

http://www.w3.org/2001/XMLSchema#string